Is there a role for whole brain radiotherapy in the treatment of leptomeningeal metastases?

Journal of Thoracic Oncology

Volumn 7, Issue 7, 2012, Pages 1204-

  Chamberlain, Marc C ^a   Eaton, Keith ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DISEASE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CEREBROSPINAL FLUID CYTOLOGY; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; MENINGEAL METASTASIS; PRIORITY JOURNAL; TREATMENT OUTCOME; WHOLE BRAIN RADIOTHERAPY;

EID: 84862902243     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3182572ecf     Document Type: Letter

References (5)

1. Morris PG, Reiner AS, Szenberg OR, et al. Leptomeningeal Metastasis from Non-small Cell Lung Cancer: Survival and the Impact of Whole Brain Radiotherapy. J Thorac Oncol 2012;7:382-385.
2. Brem SS, Bierman PJ, Brem H, et al.; National Comprehensive Cancer Network. Central nervous system cancers. J Natl Compr Canc Netw 2011;9:352-400.
3. Chamberlain MC Kormanik PA. Prognostic significance of coexistent bulky metastatic central nervous system disease in patients with leptomeningeal metastases. Arch Neurol 1997;54:1364-1368. (Pubitemid 27469350)
4. Chamberlain MC Kormanik P. Carcinoma meningitis secondary to non-small cell lung cancer: combined modality therapy. Arch Neurol 1998;55:506-512. (Pubitemid 28182696)
5. Chamberlain MC. Leptomeningeal metastasis. Curr Opin Oncol 2010;22:627-635.